NIDDK GFR Calculator

NIDDK NIH Gov GFR Calculator

NIDDK GFR Equation:

\[ eGFR = 142 \times \min(Scr/\kappa, 1)^\alpha \times \max(Scr/\kappa, 1)^{-1.200} \times 0.9938^{age} \times (1.012 \text{ if female}) \]

Estimated GFR (eGFR):

Unit Converter ▲

Unit Converter ▼

From:	To:

1. What is the NIDDK GFR Calculator?

The NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) GFR calculator estimates glomerular filtration rate using a modified equation developed by NIH researchers. It provides accurate assessment of kidney function for clinical and research purposes.

2. How Does the Calculator Work?

The calculator uses the NIDDK GFR equation:

\[ eGFR = 142 \times \min(Scr/\kappa, 1)^\alpha \times \max(Scr/\kappa, 1)^{-1.200} \times 0.9938^{age} \times (1.012 \text{ if female}) \]

Where:

\( Scr \) — Serum creatinine (mg/dL)
\( \kappa \) — 0.7 (female) or 0.9 (male)
\( \alpha \) — -0.241 (female) or -0.302 (male)
\( age \) — Age in years
1.012 — Female multiplier

Explanation: This equation incorporates optimized coefficients for improved accuracy across diverse populations, with specific adjustments for gender differences in muscle mass and creatinine production.

3. Importance of eGFR Calculation

Details: Accurate GFR estimation is essential for detecting early kidney disease, monitoring disease progression, and making informed clinical decisions about treatment and medication dosing.

4. Using the Calculator

Tips: Enter serum creatinine in mg/dL, age in years, and select gender. Ensure all values are valid (creatinine > 0, age between 1-120 years). Use standardized creatinine measurements for best results.

5. Frequently Asked Questions (FAQ)

Q1: What makes the NIDDK equation different from CKD-EPI?
A: The NIDDK equation uses slightly different coefficients (142 vs 141, different exponents) and is optimized based on NIH research data for specific clinical applications.

Q2: What population was this equation validated on?
A: This equation was developed and validated using diverse populations including participants from NIH clinical trials and epidemiological studies.

Q3: How often should eGFR be monitored?
A: Frequency depends on clinical context - annually for screening, more frequently for patients with risk factors or established kidney disease.

Q4: Are there limitations to this equation?
A: Like all estimating equations, it may be less accurate in extremes of age, body composition, or in populations with unusual muscle mass.

Q5: Can this calculator be used for children?
A: No, this equation is validated for adults only. Pediatric GFR estimation requires different equations accounting for body surface area.